Insider Transactions in Q1 2023 at Zynerba Pharmaceuticals, Inc. (ZYNE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2023
|
Albert P Parker Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,173
-1.38%
|
$0
$0.54 P/Share
|
|
Feb 08
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,145
-2.15%
|
$0
$0.6 P/Share
|
|
Feb 08
2023
|
Albert P Parker Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,463
-2.32%
|
$0
$0.6 P/Share
|
|
Feb 08
2023
|
Armando Anido Chairman & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,547
-1.39%
|
$0
$0.6 P/Share
|
|
Feb 08
2023
|
Terri B Sebree President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,973
-1.74%
|
$0
$0.6 P/Share
|
|
Feb 08
2023
|
James E Fickenscher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,544
-1.81%
|
$0
$0.6 P/Share
|
|
Feb 07
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
14,926
+5.88%
|
-
|
|
Feb 07
2023
|
Albert P Parker Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,864
+7.41%
|
-
|
|
Feb 07
2023
|
Armando Anido Chairman & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,406
+4.79%
|
-
|
|
Feb 07
2023
|
Terri B Sebree President |
BUY
Grant, award, or other acquisition
|
Direct |
36,044
+5.91%
|
-
|
|
Feb 07
2023
|
James E Fickenscher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,547
+5.86%
|
-
|
|
Feb 01
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,809
-2.1%
|
$0
$0.6 P/Share
|
|
Feb 01
2023
|
Albert P Parker Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,841
-2.62%
|
$0
$0.6 P/Share
|
|
Feb 01
2023
|
Armando Anido Chairman & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,726
-1.35%
|
$0
$0.6 P/Share
|
|
Feb 01
2023
|
Terri B Sebree President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,321
-1.7%
|
$0
$0.6 P/Share
|
|
Feb 01
2023
|
James E Fickenscher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,927
-1.71%
|
$0
$0.6 P/Share
|
|
Jan 31
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
13,950
+5.75%
|
-
|
|
Jan 31
2023
|
Albert P Parker Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,631
+7.34%
|
-
|
|
Jan 31
2023
|
Armando Anido Chairman & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,437
+4.66%
|
-
|
|
Jan 31
2023
|
Terri B Sebree President |
BUY
Grant, award, or other acquisition
|
Direct |
33,688
+5.8%
|
-
|
|
Jan 31
2023
|
James E Fickenscher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,073
+5.74%
|
-
|
|
Jan 24
2023
|
Albert P Parker Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+45.33%
|
-
|
|
Jan 24
2023
|
Armando Anido Chairman & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+23.23%
|
-
|
|
Jan 24
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+35.84%
|
-
|
|
Jan 24
2023
|
James E Fickenscher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+34.36%
|
-
|
|
Jan 24
2023
|
Terri B Sebree President |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+24.88%
|
-
|
|
Jan 23
2023
|
Armando Anido Chairman & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
35,453
-5.8%
|
$0
$0.6 P/Share
|
|
Jan 23
2023
|
Brian Rosenberger VP, Commercial & Business Dev. |
SELL
Open market or private sale
|
Direct |
12,663
-11.78%
|
$0
$0.6 P/Share
|
|
Jan 23
2023
|
James E Fickenscher Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,769
-10.3%
|
$0
$0.6 P/Share
|
|
Jan 23
2023
|
Terri B Sebree President |
SELL
Open market or private sale
|
Direct |
24,661
-6.7%
|
$0
$0.6 P/Share
|